Literature DB >> 8740037

Follow-up of the remaining bladder after supravesical urinary diversion.

E A Granados1, J Salvador, J Vicente, H Villavicencio.   

Abstract

OBJECTIVES: To review our experience in 14 patients who underwent supravesical urinary diversion maintaining their defunctionalized bladder in situ.
METHODS: A variety of pathological entities indicated surgery, including neurogenic bladder, urinary tuberculosis (with severely contracted bladder), interstitial cystitis, and retroperitoneal fibrosis.
RESULTS: Global analysis revealed a total of 11 patients (78.5%) who presented complications, the most frequent being mucopurulent and bloody secretions (28.5%), and painful bladder spasms (14.2%), followed by hemorrhage, pyocystis, hypogastric or urethral pain, and sepsis.
CONCLUSION: Two patients (14.2%) required hospitalization for treatment of complications. The majority of complications were treated successfully with bladder irrigations and antibiotics. One patient required total cystectomy secondary to pyocystis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740037     DOI: 10.1159/000473766

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

Review 1.  Pyocystis: a systematic review.

Authors:  Mohamed H Kamel; Ramsey Gardner; Ali Tourchi; Karen Tart; Omer Raheem; Bradley Houston; Nabil Bissada; Rodney Davis
Journal:  Int Urol Nephrol       Date:  2017-03-07       Impact factor: 2.370

2.  Bladder augmentation and urinary diversion for neurogenic LUTS: current indications.

Authors:  Kamran P Sajadi; Howard B Goldman
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

Review 3.  [Long-term follow-up of the defunctionalized bladder after urinary diversion].

Authors:  F-C von Rundstedt; D Lazica; A S Brandt; M J Mathers; S Roth
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

4.  Primary mucinous adenocarcinoma in a defunctionalized urinary bladder: a case report.

Authors:  Mary Taneous; Preetha Ramalingam; Donald G Mode; Jared G Heiner; Martha K Terris; Jeffrey R Lee
Journal:  J Med Case Rep       Date:  2009-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.